Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin analogues with selective signaling properties and reduced mitogenicity

Insulin analogues with selective signaling properties and reduced mitogenicity

US Patent 10703792 · Granted Jul 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapid-acting insulin analogues of enhanced stability2025
Encapsulation of ultra-stable insulin analogues with polymer melts2023
Rapid-acting insulin analogues of enhanced stability2021
Single-chain insulin analogues stabilized by a fourth disulfide bridge2021
Biphasic single-chain insulin analogues2021
Non-standard insulin analogues2021
Insulin analogues with enhanced stability and reduced mitogenicity2020
Non-standard insulin analogues2020
Insulin analogues with a glucose-regulated conformational switch2020
Rapid action insulin formulations and pharmaceutical delivery systems2020
Insulin analogues with selective signaling properties and reduced mitogenicity2019
Biphasic single-chain insulin analogues2019